Inmed pharmaceuticals to present at the h.c. wainwright ophthalmology virtual conference

Vancouver, british columbia, aug. 12, 2021 (globe newswire) -- inmed pharmaceuticals inc. (“inmed” or the “company”) (nasdaq: inm), a clinical-stage company developing cannabinoid-based pharmaceutical drug candidates as well as manufacturing technologies for pharmaceutical-grade rare cannabinoids, today announced that eric. a. adams, president and ceo, and dr. eric hsu, senior vice president of pre-clinical research & development, will present at h.c. wainwright ophthalmology virtual conference on tuesday, august 17, 2021.
INM Ratings Summary
INM Quant Ranking